Follow Us:
Thursday, October 22, 2020



Cipla shares rally 10% after Q1 earnings

August 10, 2020 1:12 pm

Cipla stock zoomed 9.99 per cent to Rs 801.45 -- its 52-week high -- on the BSE. It rose sharply by 9.99 per cent to its one-year high of Rs 801.50 on the NSE.

Collaborating with govt agencies to develop treatment for COVID-19: Cipla

August 05, 2020 5:00 pm

The Mumbai-based drug firm is also ramping up manufacturing of essential drugs required in the fight against the pandemic.

Cipla set to undercut rivals with generic remdesivir for Covid treatment: Sources

July 09, 2020 7:21 am

Cipla India business chief executive officer and executive vice president Nikhil Chopra said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing or dosage.

Cipla chairman: Government steps encouraging, but don’t ignore chronic ailments

March 29, 2020 2:26 pm

Amid the coronavirus pandemic, The Indian Express caught up with Cipla chairman Y K Hamied to find out how they are preparing to meet this challenge.

Cipla shares rise following Vysov anti-diabetic drug acquisition

December 17, 2019 11:56 am

The homegrown pharma major on Monday said it has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the Indian market from Novartis.

Cipla infringing Roche’s patent in lung cancer drug, says Delhi HC

November 28, 2015 1:36 am

Delhi HC refused to issue any injunction against Cipla restraining it from manufacturing the medicine, after observing that the life of the patent granted to Roche was ending in March 2016.

Cipla enhances US push with 2 buys for $550 mn

September 05, 2015 3:07 am

Cipla will as a result of these acquisitions gain multiple products in the areas of anti-infectives, diabetes and central nervous system disorders.

Cipla’s gain in German firm’s drug patent loss

March 11, 2015 1:50 am

Cipla had challenged the patent, arguing that Tiotropium bromide monohydrate, sold under the brand name Spiriva.

Cipla challenges HC order against manufacturing generic drug

January 14, 2015 8:40 am

Cipla had last year started manufacturing and selling a generic drug using the Indacaterol maleate salt.

HC bars Cipla from selling drug containing Indacaterol

January 10, 2015 2:24 am

The firm has been selling the drug in India under the trademark ‘Onbrez’ through Lupin since 2010.